Zobrazeno 1 - 10
of 111
pro vyhledávání: '"T. Doughty"'
Autor:
Andrew L Mammen, Jarushka Naidoo, Divyanshu Dubey, Michael Dougan, Teilo H Schaller, Meghan J Mooradian, Douglas B Johnson, Jorg Dietrich, Leyre Zubiri, Tomas G Neilan, Bianca D Santomasso, Allison Betof Warner, Justine V Cohen, Nancy Wang, Jenny Linnoila, Jeffrey M Gelfand, Anthony A Amato, Stacey L Clardy, David A Reardon, William C Louv, Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Priscilla K Brastianos, Tracey A Cho, Christopher T Doughty, Jeffrey T Guptill, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Maria Martinez-Lage, Krista M Rubin, Karin Woodman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Expanding the US Food and Drug Administration–approved indications for immune checkpoint inhibitors in patients with cancer has resulted in therapeutic success and immune-related adverse events (irAEs). Neurologic irAEs (irAE-Ns) have an incidence
Externí odkaz:
https://doaj.org/article/a2206707f599451b8603379684ad2015
Publikováno v:
Current Treatment Options in Neurology. 24:217-239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b34589d5f5e0caee2bfc24b0621156e5
https://doi.org/10.1007/s11940-022-00718-3
https://doi.org/10.1007/s11940-022-00718-3
Autor:
Imran Hossain, Chao Tan, Phillip T. Doughty, Gaurab Dutta, Teresa A. Murray, Shabnam Siddiqui, Leonidas Iasemidis, Prabhu U. Arumugam
Publikováno v:
Frontiers in Neuroscience, Vol 12 (2018)
Gamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter that is essential for normal brain function. It is involved in multiple neuronal activities, including plasticity, information processing, and network synchronization. Abnormal GAB
Externí odkaz:
https://doaj.org/article/e3ce5441cc984d819f17ab56ce2af4f4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shayna Sarosiek, Helmut G Rennke, Catherine A. Flynn, Christopher T Doughty, Andrew R. Branagan, Steven P Treon, Jorge J. Castillo
Publikováno v:
Blood. 140:6507-6508
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48a7e52b3c2efd2cf452d37c71ca0b43
https://doi.org/10.1182/blood-2022-169977
https://doi.org/10.1182/blood-2022-169977
Publikováno v:
Neurology: Education. 2:e200043
Introduction and Problem StatementNeurology residency training is inpatient focused, underemphasizing outpatient disorders. We implemented a novel didactic series of facilitated discussions between a patient and their outpatient neurologist to expose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63aac6a14f45c266dd19e5777c37c29c
https://doi.org/10.1212/ne9.0000000000200043
https://doi.org/10.1212/ne9.0000000000200043
Autor:
Meabh O'Hare, Christopher T. Doughty
Publikováno v:
Seminars in Neurology. 39:749-760
Myasthenia gravis is an antibody-mediated autoimmune disorder of the post-synaptic neuromuscular junction resulting in fluctuating, fatigable weakness. Most patients first present with extraocular symptoms (diplopia and/or ptosis), and in 15% of case
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::840588200ed7ecc096d9beb68f5f3cf3
https://doi.org/10.1055/s-0039-1700527
https://doi.org/10.1055/s-0039-1700527
Publikováno v:
CONTINUUM: Lifelong Learning in Neurology. 25:1712-1731
This article reviews the pathogenesis, clinical features, and management of toxic myopathy related to common medications, critical illness, and illicit substances.Muscle symptoms are common among statin users and are usually reversible after disconti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de4db36aaeb0397ea83aab0e17454a3c
https://doi.org/10.1212/con.0000000000000806
https://doi.org/10.1212/con.0000000000000806
Publikováno v:
MusclenerveREFERENCES. 64(6)
INTRODUCTION/AIMS Optimal management of myasthenia gravis (MG) in individuals ≥65 y old is unknown and patient factors may limit therapeutic choices. Safety and efficacy of rituximab in older patients with MG has not been well-studied. METHODS This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6373c778a4a624510e0e69da3ed07636
https://pubmed.ncbi.nlm.nih.gov/34546572
https://pubmed.ncbi.nlm.nih.gov/34546572
Autor:
Amanda C. Guidon, Vern C. Juel, William C Louv, Justine V. Cohen, Jenny J. Linnoila, David A. Reardon, Leyre Zubiri, Christopher T. Doughty, Priscilla K. Brastianos, Jeffrey T. Guptill, Jeffrey M. Gelfand, Douglas B. Johnson, Nicole R. LeBoeuf, Divyanshu Dubey, Jorg Dietrich, Andrew L. Mammen, Jarushka Naidoo, Tomas G. Neilan, Anthony A. Amato, Bart K Chwalisz, Robert Kadish, Ryan J. Sullivan, Noah Kolb, Allison Betof Warner, Karin Woodman, Michael Dougan, Nancy Wang, Meghan J. Mooradian, Bianca Santomasso, Teilo H Schaller, Maria Martinez-Lage, Krista M. Rubin, Tracey A. Cho, James M. Hillis, Leeann B Burton, Kerry L. Reynolds, Stacey L. Clardy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Expanding the US Food and Drug Administration–approved indications for immune checkpoint inhibitors in patients with cancer has resulted in therapeutic success and immune-related adverse events (irAEs). Neurologic irAEs (irAE-Ns) have an incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74365620d1800efbf037aaed24e29b69
https://jitc.bmj.com/content/9/7/e002890.full
https://jitc.bmj.com/content/9/7/e002890.full